Editorial Commentary
When not having a tissue may not be an issue in advanced lung cancer
Chinese Clinical Oncology
2023;
12
(4)
:32
.
(31 August 2023)
Searching for the optimal sequence of dual-targeted CAR T cells in relapsed/refractory acute lymphoblastic leukemia
Chinese Clinical Oncology
2023;
12
(4)
:33
.
(31 August 2023)
Positivity of the KEYNOTE-394 but negativity of the KEYNOTE-240: differences in efficacy between Eastern and Western populations?
Chinese Clinical Oncology
2023;
12
(4)
:34
.
(31 August 2023)
Original Article
Utility of psychotherapy assessed with Kessler scale in a population of cancer patients undergoing systemic oncological treatment: a mono-institutional experience
Chinese Clinical Oncology
2023;
12
(4)
:35
.
(31 August 2023)
Efficacy of scalp-sparing volumetric-modulated arc therapy approach in reducing scalp radiation dose for patients with glioblastoma: a cross-sectional study
Chinese Clinical Oncology
2023;
12
(4)
:36
.
(31 August 2023)
Phosphotriesterase-related protein as a novel prognostic predictor for hepatocellular carcinoma patients
Chinese Clinical Oncology
2023;
12
(4)
:37
.
(31 August 2023)
Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study
Chinese Clinical Oncology
2023;
12
(4)
:38
.
(31 August 2023)
Review Article
Next stage of collaboration in East Asia gastric cancer treatment
Chinese Clinical Oncology
2023;
12
(4)
:39
.
(31 August 2023)
A review on paying for advanced cancer therapeutics: hard truths and realities in Asia
Chinese Clinical Oncology
2023;
12
(4)
:40
.
(31 August 2023)
Role of radiotherapy and its contribution to immunotherapy in hepatocellular carcinoma
Chinese Clinical Oncology
2023;
12
(4)
:41
.
(31 August 2023)
Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigm
Chinese Clinical Oncology
2023;
12
(4)
:42
.
(31 August 2023)
Treatment strategy for de novo metastatic nasopharyngeal carcinoma: a literature review
Chinese Clinical Oncology
2023;
12
(4)
:43
.
(31 August 2023)
Mini-Review
The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancer
Chinese Clinical Oncology
2023;
12
(4)
:44
.
(31 August 2023)
Case Report
First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma
Chinese Clinical Oncology
2023;
12
(4)
:45
.
(31 August 2023)
